Clariant completes sale of Pharmaceutical Fine Chemicals
Advertisement
After fulfilment of local transfer requirements and approval of all relevant authorities, Clariant has completed the sale of its Pharmaceutical Fine chemicals unit to TowerBrook Capital Partners, L.P. on June 30th 2006 for a transaction value of CHF 110 million.
The Pharmaceutical Fine Chemicals unit, part of the Life Science Chemicals Division, is subsequently reported as discontinued operation.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.